Han Ying
Chief Tech/Sci/R&D Officer at IMMUNOTECH BIOPHARM LTD
Profile
Han Ying is the founder of Gene Corp., which was founded in 2021.
Dr. Ying is currently the Chief Executive Officer & Director at Gyre Therapeutics, Inc. since 2023 and the Chief Scientific Officer at Immunotech Biopharm Ltd.
Dr. Ying previously worked as a Director at Base Therapeutics.
Dr. Ying obtained a doctorate degree from Stanford University and completed undergraduate and graduate degrees from Peking University.
Han Ying active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Chief Tech/Sci/R&D Officer | - |
Former positions of Han Ying
| Companies | Position | End |
|---|---|---|
Gene Corp.
 Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Founder | - |
Training of Han Ying
| Stanford University | Doctorate Degree |
| Peking University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Private companies | 1 |
|---|---|
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Retail Trade |
- Stock Market
- Insiders
- Han Ying
